Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Mauna Kea Technologies SA

Mauna Kea Technologies SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)0.3515
  • Today's Change0.010 / 2.78%
  • Shares traded175.73k
  • 1 Year change-37.23%
  • Beta1.2595
Data delayed at least 15 minutes, as of Sep 30 2024 14:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mauna Kea Technologies SA formerly Mauna Kea Technologies SAS is a France-based medical device manufacturing company. The Company specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. It provides Cellvizio product that is used by medical specialties and is revolutionizing the way physicians diagnose and treat patients making a transformative change in medicine. Its real-time in vivo cellular imaging platform, that delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time.

  • Revenue in EUR (TTM)10.48m
  • Net income in EUR-3.73m
  • Incorporated2000
  • Employees68.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Spineguard SA4.31m-4.18m6.89m24.00--1.27--1.60-0.107-0.1070.11040.12560.38271.284.68179,700.00-37.12-23.69-52.43-42.7372.8975.60-97.00-45.021.73-13.510.3384---22.98-10.65-74.81--89.42--
Alpha Mos SA4.51m-4.74m10.01m53.00------2.22-0.4345-0.43450.4127-0.74280.5992.937.3685,000.00-63.06-47.80-521.78-139.0945.5568.00-105.28-68.640.2498-7.77-----22.464.97-76.91---18.75--
Bluelinea SA9.83m-1.62m10.35m86.00--3.8586.411.05-0.1319-0.13190.80020.21850.81870.25817.00114,260.40-13.49-26.29-28.47-58.2999.2592.43-16.48-29.240.5362-32.470.5757---5.599.78-4.91--20.53--
Aton SA1.56k-563.57k10.58m17.00------6,784.85-0.0021-0.00210.00001-------------47.55---60.70-23,780.77---36,126.28-3,320.95--------24,396.7937.77-3,244.13------
Implanet SA7.30m-6.91m13.62m41.00--4.07--1.87-0.1305-0.12260.09790.0280.52270.79273.83179,262.90-49.48-37.44-111.96-86.7455.2259.59-94.67-67.430.5906-14.510.5671---7.242.08-88.59---2.20--
Laboratoires Euromedis SA34.04m13.11m14.64m54.001.130.65831.100.43024.604.6011.667.930.64153.053.92630,347.6024.718.7634.6512.450.533815.5738.526.101.46-26.380.3031---37.18--320.97------
Theraclion SA1.82m-3.68m15.05m29.00--3.32--8.26-0.0811-0.08110.03970.12360.11180.10810.680762,835.52-22.54-32.98-30.99-48.0181.8860.85-201.68-249.162.86-40.630.2564--47.49-1.1325.97---7.23--
Intrasense SA3.31m-3.58m15.27m74.00--2.01--4.62-0.0697-0.06970.06440.13960.3897--4.0644,662.16-42.20-29.51-58.14-43.1289.0887.59-108.29-54.42---32.280.1697---12.801.53-4.65------
Ikonisys SA448.56k-2.27m16.51m10.00--1.02--36.81-0.233-0.2330.04611.620.02111.1832.2144,856.00-10.65---12.50---20.88---505.54--0.0619-29.680.1244---27.28--7.38------
Diagnostic Medical Systems SA42.15m-9.76m17.11m147.00--1.38--0.4059-0.4982-0.24812.230.70230.80271.816.81286,755.10-18.73-12.33-33.53-22.1437.5837.72-23.33-16.450.7105-3.520.5938--19.5111.62-106.30------
Mauna Kea Technologies SA10.48m-3.73m21.54m68.00------2.06-0.0578-0.05780.2126-0.28090.49052.312.45154,117.60-17.45-51.23-223.84-93.3033.6211.15-35.57-142.410.42874.292.38--40.139.1666.66---21.16--
Global Bioenergies SA486.33k-7.36m27.86m46.00------57.29-0.4036-0.40360.0267-0.00810.02762.740.118810,572.39-41.78-43.66-99.83-82.47-600.24-948.35-1,513.81-1,331.360.8447------365.8336.2527.78---19.49--
Data as of Sep 30 2024. Currency figures normalised to Mauna Kea Technologies SA's reporting currency: Euro EUR

Institutional shareholders

2.32%Per cent of shares held by top holders
HolderShares% Held
OFI Invest Asset Management SAas of 29 Feb 2024712.09k1.15%
UBS LA MAISON de Gestionas of 30 Dec 2022675.00k1.09%
Pure Capital SAas of 30 Jun 202355.00k0.09%
Data from 31 Dec 2023 - 31 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.